Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD Approval Request...???

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 11, 2022 2:28pm

300 Views

Post# 34594472

RE:RE:RE:RE:RE:RE:BTD Approval Request...???

I mean imagine what share price would do? I don't think the data was quite there to mention BTD in this last PR, which many here were calling for... Anyway, once BTD is applied for/approved. Then TLT announces a NSCLC Phase 1 with x-ray activation as it's Dosimetry. Or a partnership with Health Canada for a Covid Vaxx. And, an update of this NMIBC trial with good/better/great results.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec